| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2009;40:S4.)
© 2009 American Heart Association, Inc.
Neurovascular Unit |
From the Neuroprotection Research Laboratory, Departments of Radiology and Neurology, Massachusetts General Hospital and Program in Neuroscience, Harvard Medical School, Charlestown, Mass.
Correspondence to Eng H. Lo, PhD, Neuroprotection Research Laboratory, MGH East 149-2401, 13th Street, Charlestown, MA 02129. E-mail Lo{at}helix.mgh.harvard.edu
The fundamental premise of neuroprotection has historically focused on the prevention of neuronal death. However, despite tremendous advances in the molecular biology of intraneuronal mechanisms and pathways, a clinically effective neuroprotectant does not yet exist. This problem is especially clear for stroke, for which a large number of neuroprotection trials have failed. The concept of the neurovascular unit emphasizes that cell-cell signaling among the various neuronal, glial, and vascular compartments underlies the homeostasis of normal brain function. Conversely, dysfunctional signaling within the neurovascular unit should contribute to disease. This minireview surveys recent data that support this basic idea, with examples drawn from experimental models broadly relevant to stroke and neurodegeneration.
Key Words: neuroprotection cell-cell signaling
This article has been cited by other articles:
![]() |
K. Arai and E. H. Lo An Oligovascular Niche: Cerebral Endothelial Cells Promote the Survival and Proliferation of Oligodendrocyte Precursor Cells J. Neurosci., April 8, 2009; 29(14): 4351 - 4355. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |